Perikardiyal Efüzyon

Öz

Perikardiyal efüzyon perikardiyal boşlukta önemli miktarda sıvı birikmesidir. Perikardiyal efüzyonlara perikardit veya miyokardit ile sonuçlanan durumlar (neoplastik, otoimmün, metabolik, bulaşıcı) neden olabilir. En iyi tanı yöntemi ekokardiyografidir. Bu yöntemde, boyutu ve yerelleştirmeyi tahmin etmek kolaydır. Semptomlar hafif ila şiddetli arasında değişir ve bunlar perikardit veya kalp tamponadı ile ilişkilidir. Birçok perikardiyal efüzyon herhangi bir tedavi gerektirmemesine rağmen, bu durum hemodinamik etki, boyut, inflamasyon varlığı ve ilişkili tıbbi durumlar ile değişebilir. Ancak, kalp tamponadı varsa, perikardiyosentez yapılabilir.

Anahtar Kelimeler

• Perikardiyal efüzyon
• semptom
• tanı

Pericardial Effusion

Öz

Pericardial effusion is a significant amount of fluid accumulation in the pericardial space. Pericardial effusions can be caused by states (neoplastic, autoimmune, metabolic, infectious) that results in pericarditis or myocarditis. The best diagnostic method is echocardiography. In this method, it is easy to estimate the size and localization. Symptoms range from mild to severe and these are related to pericarditis or cardiac tamponade.Although many pericardial effusions do not require any therapy, this situation can change by the hemodynamic impact, size, presence of inflammation, and associated medical conditions. But, if there is cardiac tamponade, pericardiocentesis can be performed

Anahtar Kelimeler

• Pericardial effusion
• symptom
• diagnosis
• treatment

Kaynakça

1. 1. Sharma NK, Waymack JR. Acute Cardiac Tamponade. StatPearls [Internet]. StatPear ls Publishing; Treasure Island (FL): Dec 17, 2019.
2. 2. Troughton RW, Craig RA, Allan RK: Pericarditis. Lancet. 2004;363:717-27.
3. 3. Karam N, Patel P, De Filippi C: Diagnosis and management of chronic pericardial effusions. Am J Med Sci. 2001;322:79-87.
4. 4. Imazio M, Adler Y. Management of pericardial effusion.Eur Heart J. 2013;34:1186-97.
5. 5. Imazio M, Brucato A, Mayosi BM, et al. Medical therapy of pericardial diseases: part II: Noninfectious pericarditis, pericardial effusion and constrictive pericarditis.J Cardiovasc Med (Hagerstown). 2010;11:785-94.
6. 6. Galve E, Garcia-Del-Castillo H, Evangelista A, Batlle J, Permanyer-Miralda G, Soler-Soler J. Pericardial effusion in the course of myocardial infarction: incidence, natural history, and clinical relevance. Circulation. 1986;73:294-9.
7. 7. Figueras J, Juncal A, Carballo J, Cortadellas J, Soler JS. Nature and progression of pericardial effusion in patients with a first myocardial infarction: relationship to age and free wall rupture. Am Heart J. 2002;144:251-8.
8. 8. Posner MR, Cohen GI, Skarin AT. Pericardial disease in patients with cancer. The differentiation of malignant from idiopathic and radiation-induced pericarditis. Am J Med. 1981;71:407-13.

9. 9. Sagrista-Sauleda J. Merce 1, Permanyer-Miralda G, Soler-Soler J. Clinical clues to the causes of large pericardial effusion. Am J Med. 2000; 105:95-01.
10. 10. Porte HL, Janecki-Delebecq TJ, Finzi L, Métois DG, Millaire A, Wurtz AJ. Pericardoscopy for primary management of pericardial effusion in cancer patients. Eur J Cardiothorac Surg.Eur J Cardiothorac Surg. 1999;16:287-91
11. 11. Alerhand S, Carter JM. What echocardiographic findings suggest a pericardial effusion is causing tamponade? Am J Emerg Med. 2019;37:321-326.
12. 12. Shabetai R. Pericardial effusion: haemodynamic spectrum. Heart. 2004;90:255-6.
13. 13. Buhumaid RE, St-Cyr Bourque J, Shokoohi H, Ma IWY, Longacre M, Liteplo AS. Integrating point-of-care ultrasound in the ED evaluation of patients presenting with chest pain and shortness of breath. Am J Emerg Med. 2019;37:298-303
14. 14. Ristić AD, Imazio M, Adler Y, et alTriage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2014;35:2279-84.
15. 15. Gueberman B, Fowler N, Engel P, Gueron M, Allen JM.Cardiac tamponade in medical patients. Circulation. 1987;64:633-40.
16. 16. Hovgaard HL, Nielsen RR, Laursen CB, Frederiksen CA, Juhl-Olsen P. When appearances deceive: Echocardiographic changes due to common chest pathology. Echocardiography. 2018;3:1847-59.
17. 17. Imazio M, Mayosi BM, Brucato A, et al. Triage and management of pericardial effusion.J Cardiovasc Med (Hagerstown). 2010;11:928-35.
18. 18. Sagrista-Sauleda J, Angel J, Permanyer-Miralda G, Soler-Soler J. Long-term follow-up of idiopathic chronic pericardial effusion. N Eng J Med. 1999;34 :2054-9
19. 19. Soler-Soler J, Sagristà-Sauleda J, Permanyer-Miralda G. Relapsing pericarditis. Heart. 2004;90:1364-8.
20. 20. Imazio M, Bobbio M, Cecchi E,et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the colchicine for acute PEricarditis (COPE) trial. Circulation. 2005;112:2012-6.
21. 21. Maisch B, Seferović PM, Ristić AD, et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J. 2004;25:587–610.
22. 22. Imazio M, Demichelis B, Parrini I, et al. Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. J Am Coll Cardiol. 2004;43:1042-6.
23. 23. Tsang TS, Seward JB, Barnes ME, et al. Outcomes of primary and sccondary treatment of pericardial effusion in patients with malignancy. Mayo Clin Proc 2000:75:248-53.
24. 24. Maisch B. [Management of pericarditis and pericardial effusion, constrictive and effusive-constrictive pericarditis]. Herz. 2018;43:663-78.
25. 25. Vaitkus PT, Herrmann HC, Le Winter MM. Treatment of malignant pericardial effusion. JAMA. 1994;272:59-64.
26. 26. Palacios IF, Tuzcu EM, Ziskind AA, Younger J, Block PC. Percutaneous balloon pericardial window for patients with malignant pericardial effusion and tamponade. Cathet Cardiovasc Diagn. 1991;22:244-9.
27. 27. Swanson N, Mirza I, Wijesinghe N, Devlin G. Primary percutaneous balloon peri cardiotomy for malignant pericardial effusion. Catheter Cardiovasc Interv. 2008;71:504-7.
28. 28. Wang HJ, Hsu KL, Chiang FT, Tseng CD, Tseng YZ, Liau CS. Technical and prognostic outcomes of double-balloon pericardiotomy for large malignancy-related pericardial effusions. Chest. 2002;122:893-9.
29. 29. Lashevsky I, Ben Yosef R, Rinkevich D, Reisner S, Markiewicz W.lntrapericardial minoksiklin sclerosis for malignant pericardial effusion. Chest 1996;109:1452-4
30. 30. Piehler JM, Pluth JR, Schaff HV, Danielson GK, Orszulak TA, Puga FJ. Surgical management of effusive pericardial disease. Influence of extent of pericardial resection on clinical course. J Thorac Cardiovasc Surg. 1985;90:506-16.
31. 31. Mitiku TY, Heidenreich PA. A small pericardial effusion is a marker of increased mortality.Am Heart J. 2011;161:152-7.